Kidney cancer, Renal cell cancer
Results
Phase 3
This trial looked at a drug called rocapuldencel-T for kidney cancer that has spread.
People could join the trial between 2012 and 2016. The research team published the results in 2020.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 November 2012
Recruitment end: 31 May 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Eisen
Argos Therapeutics
NIHR Clinical Research Network: Cancer
Last reviewed: 06 Oct 2026
CRUK internal database number: 11894